c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells
- PMID: 21872498
- DOI: 10.1016/j.urolonc.2010.11.011
c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells
Abstract
Objective: To uncover the role of c-Jun, a proto-oncogene, in inhibitory effects of antiproliferative factor (APF) on tumor cell growth.
Materials and methods: Expression of c-Jun was analyzed by Western blotting in 45 clinical specimens (30 tumorous tissues and 15 paired non-tumorous tissues) and 3 bladder cancer cell lines. APF-responsive T24 transitional carcinoma bladder cells were treated with APF or mock control. Cell proliferation was measured by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay. Change of c-Jun expression was detected by RT-PCR and Western blotting. The influence of c-Jun on APF treatment was evaluated by transient transfection of c-Jun and MTT assay in T24 cells.
Results: c-Jun was significantly higher in invasive bladder cancer tissues and cell lines. T24 cells treated with APF had decreased c-Jun expression and suppressed cell growth. More importantly, ectopic c-Jun attenuated APF inhibitory effects on cell growth.
Conclusions: These observations suggest that c-Jun is involved in APF-mediated inhibition for bladder tumor cell growth, as potential target of APF in patients with aggressive bladder carcinoma.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.J Exp Clin Cancer Res. 2010 Dec 10;29(1):160. doi: 10.1186/1756-9966-29-160. J Exp Clin Cancer Res. 2010. PMID: 21143984 Free PMC article.
-
Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.Urol Int. 2012;88(1):95-101. doi: 10.1159/000331881. Epub 2011 Oct 25. Urol Int. 2012. PMID: 22041818
-
Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation.BJU Int. 2009 Feb;103(4):541-6. doi: 10.1111/j.1464-410X.2008.08097.x. Epub 2008 Oct 16. BJU Int. 2009. PMID: 18990151 Free PMC article.
-
Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.Urol Oncol. 2012 Nov-Dec;30(6):920-7. doi: 10.1016/j.urolonc.2010.10.003. Epub 2011 Apr 7. Urol Oncol. 2012. PMID: 21478038
-
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.Clin Cancer Res. 2003 Nov 1;9(14):5346-57. Clin Cancer Res. 2003. PMID: 14614020
Cited by
-
Predicting bladder cancer survival with high accuracy: insights from MAPK pathway-related genes.Sci Rep. 2024 May 7;14(1):10482. doi: 10.1038/s41598-024-61302-0. Sci Rep. 2024. PMID: 38714855 Free PMC article.
-
Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.Diagnostics (Basel). 2021 Nov 30;11(12):2238. doi: 10.3390/diagnostics11122238. Diagnostics (Basel). 2021. PMID: 34943475 Free PMC article. Review.
-
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.Med Sci Monit. 2019 Apr 25;25:3041-3060. doi: 10.12659/MSM.915487. Med Sci Monit. 2019. PMID: 31020952 Free PMC article.
-
Antiproliferative factor signaling and interstitial cystitis/painful bladder syndrome.Int Neurourol J. 2011 Dec;15(4):184-91. doi: 10.5213/inj.2011.15.4.184. Epub 2011 Dec 31. Int Neurourol J. 2011. PMID: 22259731 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
